Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Ongoing and planned phase 2 studies will determine whether its selective FGFR1/-Klotho activation and long-acting antibody format justify progression to large-scale histologic and outcome-based trials
Energy 1.5 kcal
The 15 mg weekly dose typically showed the highest incidence of gastrointestinal effects across studies
Mutational heterogeneity in cancer and the search for new cancer-associated genes
US$ 29.33
US$ 21.82
US$ 20.78
US$ 25.99
